Showing 381 - 400 results of 677 for search '"Cancer treatment"', query time: 0.06s Refine Results
  1. 381

    Impact of Undetected Comorbidity on Treatment and Outcomes of Breast Cancer by Robert I. Griffiths, Michelle L. Gleeson, José M. Valderas, Mark D. Danese

    Published 2014-01-01
    “…Preexisting comorbidity adversely impacts breast cancer treatment and outcomes. We examined the incremental impact of comorbidity undetected until cancer. …”
    Get full text
    Article
  2. 382

    Targeted Photodynamic Therapy: A Novel Approach to Abolition of Human Cancer Stem Cells by Anine Crous, Elvin Chizenga, Natasha Hodgkinson, Heidi Abrahamse

    Published 2018-01-01
    “…The discovery of CSCs has initiated extensive research into novel cancer treatment regimes. Evidence indicates that CSCs are resistant to conventional chemo- and radiation therapy leading to treatment failures, cancer metastasis, secondary cancer formation, and relapse. …”
    Get full text
    Article
  3. 383

    Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro by Windy Aristiani, Widea Rossi Desvita, Dika Khayatulisma, Citra Ariani Edityaningrum, Any Guntarti, Laela Hayu Nurani

    Published 2024-04-01
    “…These findings suggest a promising avenue for enhancing the therapeutic potential of doxorubicin in cervical cancer treatment while minimizing adverse effects.…”
    Get full text
    Article
  4. 384

    Research Hotspots and Trends in Acupuncture for Cancer:A bibliometric analysis from 2004 to 2024 by Ji Z, Niu H, He A, Li K, Jia J, Zhang M, Liu G

    Published 2025-01-01
    “…Zhe Ji,* Heyuan Niu,* Anqi He, Kaiyu Li, Jinyan Jia, Maorun Zhang, Gang Liu Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China*These authors contributed equally to this workCorrespondence: Gang Liu, Email lg1059@tmu.edu.cnBackground: Acupuncture is increasingly recognized as a promising intervention modality in cancer treatment. Nevertheless, there has been a paucity of systematic analysis and visualisation of relevant publications through bibliometric methods. …”
    Get full text
    Article
  5. 385

    Tumor microbiome: roles in tumor initiation, progression, and therapy by Shengxin Zhang, Jing Huang, Zedong Jiang, Huan Tong, Xuelei Ma, Yang Liu

    Published 2025-02-01
    “…Furthermore, we explore innovative microbe-based therapeutic strategies, such as engineered bacteria, oncolytic virotherapy, and other modalities aimed at enhancing immunotherapeutic efficacy, paving the way for microbiome-centered cancer treatment frameworks.…”
    Get full text
    Article
  6. 386

    Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer by Carmine Carbone, Geny Piro, Vincenzo Di Noia, Ettore D’Argento, Emanuele Vita, Miriam Grazia Ferrara, Sara Pilotto, Michele Milella, Giovanni Cammarota, Antonio Gasbarrini, Giampaolo Tortora, Emilio Bria

    Published 2019-01-01
    “…Lung cancer is one of the deadliest and most common malignancies in the world, representing one of the greatest challenges in cancer treatment. Immunotherapy is rapidly changing standard treatment schedule and outcomes for patients with advanced malignancies. …”
    Get full text
    Article
  7. 387
  8. 388

    The Multifaceted Roles of MicroRNA-181 in Stem Cell Differentiation and Cancer Stem Cell Plasticity by Chun Yang, Rui Wang, Pierre Hardy

    Published 2025-01-01
    “…Modulation of miR-181 expression has been found to be altered in cancer stem cells’ biological behaviors and to significantly improve cancer treatment outcomes. Additionally, we discuss challenges in miRNA-based therapies and targeted delivery with nanotechnology-based systems.…”
    Get full text
    Article
  9. 389

    Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges by Man Wang, Fei Yu, Yuan Zhang

    Published 2025-01-01
    “…Nanomaterials carrying anticancer agents to the target site are considered as practical approaches for cancer treatment. Nanomedicine combined with immunotherapies offers the possibility to potentiate systemic antitumor immunity and to facilitate selective cytotoxicity against cancer cells in an effective and safe manner. …”
    Get full text
    Article
  10. 390

    Women's Quality of Life After Surgical Treatment for Breast Cancer by Daniel Alejandro Arroyo Zumarraga, Ximena Elizabeth Trujillo Romero, Miguel Ramos Argilagos

    Published 2023-10-01
    “…Women who completed cancer treatment experienced less sexual dysfunction than those still undergoing treatment. …”
    Get full text
    Article
  11. 391

    Childhood cancer and parental mental health: role of disease severity, socioeconomic status, and social dynamics by Hawkar Ibrahim, Azad Ali Ismail, Narin Ahmed Rahim, Benjamin Iffland, Frank Neuner

    Published 2025-01-01
    “…Methods This prospective, cross-sectional study examined the mental health of 307 Kurdish parents of children undergoing cancer treatment in the Kurdistan Region of Iraq (KRI). …”
    Get full text
    Article
  12. 392

    Long-term cardiac MRI follow up of MANTICORE (Multidisciplinary Approach to Novel Therapies in Cardio-Oncology REsearch) by Dina Labib, Mark Haykowsky, Emer Sonnex, John R. Mackey, Richard B. Thompson, D. Ian Paterson, Edith Pituskin

    Published 2025-02-01
    “…The study also highlights the need for further research to understand the significance of changes in cardiac geometry during and after breast cancer treatment​.…”
    Get full text
    Article
  13. 393

    RNA binding protein ILF3 increases CEP55 mRNA stability to enhance malignant potential of breast cancer cells and suppress ferroptosis by Sheng Chen, Yangyong Luo, Simin Ruan, Guosen Su, Guoxing Huang

    Published 2025-01-01
    “…Abstract Background Ferroptosis has emerged as a promising therapeutic target in cancer treatment. CEP55, a key regulator of cell mitosis, plays a significant role in the tumorigenesis of many malignancies. …”
    Get full text
    Article
  14. 394

    Magnetic and pH sensitive nanocomposite microspheres for controlled temozolomide delivery in glioblastoma cells by Meysam Ahmadi, Muhammad Hossein Ashoub, Kamran Heydaryan, Sanaz Abolghasemi, Elmuez A. Dawi, Ghazal khajouei, Mahnaz Amiri

    Published 2024-12-01
    “…Abstract Controlled drug delivery systems have been intensively researched for cancer treatment to increase precision targeting and therapeutic efficacy. …”
    Get full text
    Article
  15. 395

    Adipokines in Breast Cancer: Decoding Genetic and Proteomic Mechanisms Underlying Migration, Invasion, and Proliferation by Ließem A, Leimer U, Germann GK, Köllensperger E

    Published 2025-01-01
    “…Our findings indicate that antibodies against specific adipokines could become a beneficial component of clinical breast cancer treatment in the future.Keywords: breast cancer, adipokines, tumor progression, adipose tissue, secretome…”
    Get full text
    Article
  16. 396

    Azurin a potent anticancer and antimicrobial agent isolated from a novel Pseudomonas aeruginosa strain by Nourhan A. Zaghloul, Mona K. Gouda, Yasser Elbahloul, Nancy M. El Halfawy

    Published 2025-01-01
    “…Overall, the research findings suggest that the local isolate, P. aeruginosa strain 105, could be a potential source of azurin protein for incorporation into cancer treatment strategies.…”
    Get full text
    Article
  17. 397

    Evaluation of the Effects of Astragalus membranaceus on the Pharmacokinetics of Pemetrexed Disodium and Gemcitabine in Rats by a Simple High-Performance Liquid Chromatography/UV Me... by Zixuan Chu, Zhiyuan Wang, Teng Liu, Shan Xiong, Bin Liu

    Published 2019-01-01
    “…Combination therapy is opted as a potential therapeutic strategy for cancer treatment. Astragalus membranaceus combined with pemetrexed disodium or gemcitabine could reinforce the overall effects and alleviate the adverse effects. …”
    Get full text
    Article
  18. 398

    A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim by Joseph Mort, Shipra Maheshwari, Nayanika Basu, Patrick Dillon, Kevin Brady, Harry Bear, Trish Millard

    Published 2022-01-01
    “…Checkpoint inhibitors (CPIs) and pegfilgrastim, a long-acting growth factor agent, are vital components of current cancer treatments. Immune-related adverse events (irAEs) such as colitis and pneumonitis are well-established toxicities associated with CPI therapy. …”
    Get full text
    Article
  19. 399

    Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2pos Breast Cancer by Nirmala Ghimirey, Chase Steele, Brian J. Czerniecki, Gary K. Koski, Loral E. Showalter

    Published 2021-01-01
    “…Although immune-based therapies have made remarkable inroads in cancer treatment, they usually must be combined with standard treatment modalities, including cytotoxic drugs, to achieve maximal clinical benefits. …”
    Get full text
    Article
  20. 400

    Sempervirine inhibits proliferation, invasion and metastasis of ovarian cancer cells and induces ultrastructural changes in vivo by Danni Chen, Yan Tan, Tingting Chen, Qin Wang, Yan Yan, Xiaoya Zhao, Zhongxiao Zhang, Jin Qiu, Jian Zhang

    Published 2025-01-01
    “…Therefore, it is urgent to develop novel therapeutics for ovarian cancer treatment. In this study, we evaluated the anti-ovarian cancer effects of sempervirine in vitro and in vivo. …”
    Get full text
    Article